Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Maybe PTSC started a heavy buyback with the money from past licenses

IMO something changed since December 2011 when PTSC increased the purchase of its shares - maybe the reason for the timely odd anouncements of the last licencees was to hold the shareprice as low as possible to buy as much as possible...until AFTER the shareholder meeting.
This implies some news are coming after the bell.

But IMO 5mio shares traded can't be explained by the TYCO license.

GLTA

Share
New Message
Please login to post a reply